7 Stocks Under $10 With Relative Strength
Alexza Pharmaceuticals
Alexza Pharmaceuticals (ALXA) is a pharmaceutical company focused on the research, development, and commercialization of products for the acute treatment of central nervous system conditions. This stock is trading up 14.86% to $4.56 in recent trading.
Today's Range: $4.28-$4.99
52-Week Range: $2.55-$19.10 Volume: 2.7 million Three-Month Average Volume: 216,325 Shares of ALXA are soaring today after the company said it has resubmitted its application for Adasuve, which is a schizophrenic and bipolar disorder treatment. From a technical perspective, ALXA is gapping up big here back above its 50-day moving average of $4.39 with monster volume. This move is following a large gap-up on Friday that also occurred with monster volume. Traders should now look for long-biased trades once ALXA takes out today's high of $4.99 with high-volume. Look for a sustained move or close above $4.99 with volume that's near or above 216,325 shares. If we get that action soon, then ALXA could fill a previous gap-down in price from back in May that took the stock from $6 to under $4. A high-volume move above $4.99 could mean we see $6 or possibly even $7.60. Alexza shows up on a recent list of Hot Biotech Stocks Traded by Hedge Funds.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
